Targeting Dendritic Cell Dysfunction to Circumvent anti-PD1 Resistance in Head and Neck Cancer.
Shin SaitoMichihisa KonoHoang C B NguyenAnn Marie EgloffCameron M MessierPatrick H LizotteCloud P PaweletzDouglas R AdkinsRavindra UppaluriPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
These data highlight the contribution of tumor infiltrating cDC1s in HNSCC aPD1 response, and approaches to enhance cDC1 infiltration and function that may circumvent aPD1 resistance in HNSCC patients.